Pancreatic carcinoma-specific immunotherapy using novel tumor specific cytotoxic T cells.

about

The Development of a Novel Therapeutic Strategy to Target Hyaluronan in the Extracellular Matrix of Pancreatic Ductal Adenocarcinoma.

P2860

Q37729238-8097CDB0-AE45-4A0B-BD53-03B0680F5931

P2860

Pancreatic carcinoma-specific immunotherapy using novel tumor specific cytotoxic T cells.

Item

http://www.wikidata.org/entity/Q37696350

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Pancreatic carcinoma-specific immunotherapy using novel tumor specific cytotoxic T cells.

@en

Pancreatic carcinoma-specific immunotherapy using novel tumor specific cytotoxic T cells.

@nl

type

Item

label

Pancreatic carcinoma-specific immunotherapy using novel tumor specific cytotoxic T cells.

@en

Pancreatic carcinoma-specific immunotherapy using novel tumor specific cytotoxic T cells.

@nl

prefLabel

Pancreatic carcinoma-specific immunotherapy using novel tumor specific cytotoxic T cells.

@en

Pancreatic carcinoma-specific immunotherapy using novel tumor specific cytotoxic T cells.

@nl

P1476

Pancreatic carcinoma-specific immunotherapy using novel tumor specific cytotoxic T cells.

@en

P2093

Dong Zhang

http://www.w3.org/2001/XMLSchema#string

Jiahui Li

http://www.w3.org/2001/XMLSchema#string

Jianjun Lei

http://www.w3.org/2001/XMLSchema#string

Liang Han

http://www.w3.org/2001/XMLSchema#string

Liang Zong

http://www.w3.org/2001/XMLSchema#string

Lun Zhang

http://www.w3.org/2001/XMLSchema#string

Qingyong Ma

http://www.w3.org/2001/XMLSchema#string

Qinhong Xu

http://www.w3.org/2001/XMLSchema#string

Wanxing Duan

http://www.w3.org/2001/XMLSchema#string

Xin Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Regulation of CD40 and CD40 ligand by the AT-hook transcription factor AKNA

Cancer statistics, 2015

CD40-CD40 ligand

Molecular basis of T cell-mediated recognition of pancreatic cancer cells

The immunobiology of cancer immunosurveillance and immunoediting

Pancreatic cancer

Efficient infection of primitive hematopoietic stem cells by modified adenovirus.

Phase II clinical trial of ex vivo-expanded cytokine-induced killer cells therapy in advanced pancreatic cancer.

Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial.

Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study.

P304

83601-83610

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.13469

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27876704

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

cytotoxicity

P932

5347791

http://www.w3.org/2001/XMLSchema#string

Pancreatic carcinoma-specific immunotherapy using novel tumor specific cytotoxic T cells.

about

P2860

P2860

Pancreatic carcinoma-specific immunotherapy using novel tumor specific cytotoxic T cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932